Company Directory - MacroGenics, Inc.
Company Details - MacroGenics, Inc.
MacroGenics, Inc.
WebsiteA biotechnology company specializing in antibody-based therapies for cancer.
CCI Score
CCI Score: MacroGenics, Inc.
4.01
0.01%
Latest Event
MacroGenics, Inc. Sued for Securities Law Violations
A class action securities lawsuit was filed alleging that MacroGenics made material misrepresentations about safety data from its TAMARACK Phase 2 study, resulting in significant stock decline and investor losses.
Take Action
So what can you do? Support by shopping, spreading the word, or offering your support.
- Shop Alternatives
SEE ALL - Use Your Voice
OTHER TOOLS - Investigate
- Share the Score
SUPPORT CCI
OBJECTOR
MacroGenics, Inc. is currently rated as an Objector.
Latest Events
- SEP242024
A class action securities lawsuit was filed alleging that MacroGenics made material misrepresentations about safety data from its TAMARACK Phase 2 study, resulting in significant stock decline and investor losses.
-50
Business Practices and Ethical Responsibility
March 24
The lawsuit alleges that MacroGenics engaged in securities fraud by misrepresenting the safety data from its TAMARACK Phase 2 study, leading to severe investor losses. This unethical business practice undermines transparency and accountability, which are crucial components in resisting the influence of corporate actions that may indirectly support authoritarianism.
- SEP132024
A class action lawsuit alleges that MacroGenics, Inc. misrepresented safety data in its TAMARACK Phase 2 trial, causing a drastic drop in stock value and significant losses for investors. This incident raises serious questions about the company’s commitment to ethical business practices and transparency.
-70
Business Practices and Ethical Responsibility
March 24
MacroGenics is accused of materially misrepresenting safety data regarding its TAMARACK Phase 2 trial, which allegedly led to a catastrophic drop in stock price and significant investor losses. This behavior points to serious deficiencies in the company’s commitment to business practices and ethical responsibility, undermining shareholder trust and corporate accountability.
Understanding the MacroGenics Lawsuit: What Investors Should Know - Investors Hangout
- JAN102024
MacroGenics released its Corporate Responsibility Report for 2023, outlining its commitment to transparent and ethical business practices. The report details robust initiatives in diversity, equity and inclusion, employee welfare, environmental responsibility, and ethical research standards. These efforts serve to reinforce public trust and counter structures that may otherwise contribute to authoritarian practices.
+70
Public and Political Behavior
March 24
Although the report does not detail explicit political contributions or lobbying, MacroGenics demonstrates a transparent approach and ethical governance that enhance public trust. Their clear communication and corporate accountability, even in absence of direct political endorsements, serve as a counterbalance to authoritarian influences.
+80
Business Practices and Ethical Responsibility
March 24
The report reflects a strong commitment to ethical business practices including a comprehensive Code of Business Conduct and robust initiatives on diversity, equity, and inclusion. These proactive measures signal a high level of corporate responsibility and a meaningful effort to foster a work environment and community that resists oppressive structures.
- JAN012023
MacroGenics demonstrates its commitment to ethical and sustainable business practices through its Corporate Responsibility report. The report outlines robust ESG initiatives, board oversight, and a high level of ethical responsibility in its operations.
+80
Business Practices and Ethical Responsibility
March 24
MacroGenics' corporate responsibility page details its strong ESG initiatives and commitment to ethical business practices. The report emphasizes oversight by its senior management and Board of Directors, underpinning its dedication to environmental sustainability, social responsibility, and sound governance. From an anti-fascist perspective, this focus on ethical governance and social responsibility contrasts with the corporate complicity typically associated with supporting authoritarian practices.
Alternatives
USA
0.00
Kenilworth, United States
2.89
Somerset, United States
1.18
San Diego, United States
-30.29
New Haven, USA
-38.83
Corporation
35.43
Corporation
19.47
Corporation
2.31
Corporation
1.66
Corporation
1.00
Industries
- 325414
- Biological Product (except Diagnostic) Manufacturing
- 541712
- Research and Development in the Physical, Engineering, and Life Sciences (Biotechnology)
- 541711
- Research and Development in Biotechnology